HSBC Reiterates a “Hold” Rating on BHP Billiton PLC (LON:BLT) and GBX 1610.00 Target; Last Week Clinigen Group Plc (LON:CLIN) Analysts

Clinigen Group Plc (LON:CLIN) Logo

In a note issued on Wednesday morning, BHP Billiton PLC (LON:BLT) stock had its “Hold” Rating maintained by research professionals at HSBC. They currently have a GBX 1610.00 target price on company. HSBC’s target suggests a potential upside of 9.21% from the company’s current price.

Among 6 analysts covering Clinigen Group (LON:CLIN), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Clinigen Group had 74 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Peel Hunt on Tuesday, October 31 with “Buy”. Numis Securities maintained it with “Buy” rating and GBX 916 target in Wednesday, May 11 report. The firm earned “Buy” rating on Tuesday, October 25 by Peel Hunt. The stock of Clinigen Group Plc (LON:CLIN) earned “Buy” rating by Numis Securities on Monday, May 22. Numis Securities maintained it with “Buy” rating and GBX 916 target in Wednesday, July 20 report. Numis Securities maintained the shares of CLIN in report on Friday, June 24 with “Buy” rating. The stock of Clinigen Group Plc (LON:CLIN) earned “Buy” rating by N+1 Singer on Wednesday, January 17. The stock of Clinigen Group Plc (LON:CLIN) has “Buy” rating given on Wednesday, September 28 by Peel Hunt. Numis Securities maintained the shares of CLIN in report on Tuesday, September 22 with “Buy” rating. Peel Hunt maintained the shares of CLIN in report on Wednesday, September 13 with “Add” rating. See Clinigen Group Plc (LON:CLIN) latest ratings:

04/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
27/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Reiteration
19/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
27/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1208.00 New Target: GBX 1208.00 Maintain
27/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
18/01/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1220.00 Upgrade
17/01/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 1225.00 New Target: GBX 1225.00 Maintain
17/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain

Among 31 analysts covering BHP Billiton PLC (LON:BLT), 10 have Buy rating, 4 Sell and 17 Hold. Therefore 32% are positive. BHP Billiton PLC has GBX 1900 highest and GBX 515 lowest target. GBX 1249.61’s average target is -15.76% below currents GBX 1483.4 stock price. BHP Billiton PLC had 505 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Monday, August 17 by Deutsche Bank. The stock of BHP Billiton plc (LON:BLT) earned “Neutral” rating by Credit Suisse on Monday, September 14. The firm has “Neutral” rating by BNP Paribas given on Friday, March 11. The stock of BHP Billiton plc (LON:BLT) earned “Overweight” rating by Morgan Stanley on Wednesday, October 21. The rating was maintained by Deutsche Bank on Thursday, May 4 with “Hold”. The stock of BHP Billiton plc (LON:BLT) earned “Hold” rating by Deutsche Bank on Thursday, August 25. Barclays Capital maintained the shares of BLT in report on Wednesday, October 21 with “Overweight” rating. Jefferies maintained the stock with “Buy” rating in Tuesday, January 12 report. On Friday, January 29 the stock rating was upgraded by Credit Suisse to “Outperform”. The rating was maintained by JP Morgan on Tuesday, June 27 with “Underweight”.

BHP Billiton Plc, together with its subsidiaries, discovers, acquires, develops, and markets natural resources worldwide. The company has market cap of 78.97 billion GBP. It operates through four divisions: Petroleum, Copper, Iron Ore, and Coal. It has a 16.84 P/E ratio. The firm explores for copper, silver, lead, zinc, molybdenum, uranium, gold, and iron ores, as well as metallurgical coal, thermal energy coal, and gas and oil properties.

The stock increased 2.47% or GBX 35.8 during the last trading session, reaching GBX 1483.4. About 1.17 million shares traded. BHP Billiton plc (LON:BLT) has 0.00% since April 18, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock increased 0.28% or GBX 2.5 during the last trading session, reaching GBX 909.5. About 39,877 shares traded. Clinigen Group Plc (LON:CLIN) has 0.00% since April 18, 2017 and is . It has underperformed by 11.55% the S&P500.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally. The company has market cap of 1.11 billion GBP. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services. It has a 81.21 P/E ratio. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.